Nitric oxide versus epoprostenol for refractory hypoxemia in Covid-19.

Nitric oxide versus epoprostenol for refractory hypoxemia in Covid-19.

<h4>Objective</h4>To compare the efficacy and outcomes with inhaled nitric oxide (iNO) and inhaled epoprostenol (iEPO) in patients with refractory hypoxemia due to COVID-19.<h4>Design</h4>Retrospective Cohort Study.<h4>Setting</h4>Single health system multicenter...

Full description

Bibliographic Details
Main Authors: Pai B H Poonam, Rebecca Koscik, Trong Nguyen, Shefali Rikhi, Hung-Mo Lin
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0270646

Internet

https://doi.org/10.1371/journal.pone.0270646

Similar Items